1. Home
  2. BFS vs OABI Comparison

BFS vs OABI Comparison

Compare BFS & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saul Centers Inc.

BFS

Saul Centers Inc.

N/A

Current Price

$28.38

Market Cap

902.2M

Sector

Real Estate

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.92

Market Cap

773.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BFS
OABI
Founded
1993
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
902.2M
773.1M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
BFS
OABI
Price
$28.38
$4.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
★ $42.00
$8.33
AVG Volume (30 Days)
115.8K
★ 1.5M
Earning Date
11-05-2026
10-30-2026
Dividend Yield
★ 8.30%
N/A
EPS Growth
N/A
★ 6.56
EPS
★ 0.78
N/A
Revenue
★ $289,843,000.00
$18,666,000.00
Revenue This Year
$7.69
$94.10
Revenue Next Year
$3.08
$30.33
P/E Ratio
$36.41
★ N/A
Revenue Growth
★ 7.81
N/A
52 Week Low
$28.13
$1.35
52 Week High
$38.42
$5.45

Technical Indicators

Market Signals
Indicator
BFS
OABI
Relative Strength Index (RSI) 38.50 50.07
Support Level N/A $4.43
Resistance Level $35.04 $5.30
Average True Range (ATR) 0.64 0.38
MACD 0.01 -0.03
Stochastic Oscillator 21.09 51.36

Price Performance

Historical Comparison
BFS
OABI

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: